Life Sciences Advisory & Support Services
At Baker Tilly, our life sciences, medical device, pharmaceutical and biotech industry specialists help companies at all stages of their product and business life cycle. Whether it’s formulating a market access strategy or ensuring your company has an acceptable number of controls to mitigate risk, we are here to help.
Translating data and research to address a population’s specific need as well as navigating the unique demands of health plans, healthcare providers (HCPs) and patients is a complex exercise. At Baker Tilly, we help address all angles of bringing a product to market and having it be accepted by patients, physicians and health plans through our comprehensive set of solutions, including:
Our market access strategy and support services assist companies in executing evidence generation plans, analyzing market intelligence and pricing strategy, and facilitating payer outreach communication.
We have direct access to nationally recognized real-world data (RWD) to generate reliable evidence and understanding about the economic and clinical outcomes of products.
Whether you are an emerging life sciences company bringing your first product to market or are an established company with multiple therapies, our team can help you navigate through the commercial and medical needs of your product and business.
Our services help companies navigate through the entirety of the commercial enablement process for new and existing products through our pre-commercial assessment, field execution optimization and demand creation solutions.
Our medical affairs solutions help life sciences companies develop and execute scientific and evidence generation as well as communication plans throughout the product life cycle.
When becoming more flexible and responsive to deal with unplanned disruptions becomes essential, as was experienced during the coronavirus pandemic, our team is able to help. We assist companies mitigate risks by evaluating supply chain strengths, correcting weaknesses and realigning operations to support the business’s strategic objectives.
There is no question that life sciences companies and their executives face the fear, uncertainty and doubt of identifying, isolating and measuring risk. At Baker Tilly, our team understands the necessity of having the proper governance and controls to protect the value of your brand, and we have the solutions to further minimize these risks.
Baker Tilly provides ERM solutions tailored to life sciences organizations at each stage of evolution while considering each phase’s unique resource and risk management needs.
Our internal audit solutions help life sciences companies monitor changes in organization processes, manage internal controls, ensure quality and mitigate risks associated with commercial, medical, safety, quality, regulatory, and government pricing and contracting activities.
Our team of life sciences and litigation support specialists help our clients minimize litigation risks and navigate complex dispute resolutions.
Through evaluating third-party relationships, we are able to help life sciences companies conduct their required due diligence to ensure compliance with global anti-bribery and corruptions laws.
Baker Tilly’s customized data privacy support solutions helps companies protect the personal information of their employees and clients, comply with federal and international privacy regulations, and develop privacy protocol and checklists in case of a cyber breach.
Life sciences companies operate in a heavily regulated environment that also has intense public scrutiny. To help further protect the value of life sciences products and corporate brands, our team of compliance and ethics specialists work with clients to ensure they are operating in accordance with local, federal and international regulations, and that they are doing so with integrity.
Our team of professionals provides a comprehensive set of solutions to solve your most pressing compliance and ethics needs across all facets of life sciences organizations, including
Effectively establishing and sustaining the value of your innovative research, therapy or drug is a difficult undertaking. What complicates this even more is the fear, uncertainty and doubt that can be caused by:
We understand the complexities of not only bringing a product to market and establishing a commercial function for your organization, but also mitigating these complex risks and making sure your business is operating with integrity and in accordance with regulations.